Prestigious Prize Recognizes Pioneering Immune System Research
This year's Nobel Prize in medical science was granted for transformative findings that illuminate how the immune system targets dangerous pathogens while sparing the body's own cells.
Three renowned scientists—Japan's Prof. Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—share this accolade.
The research identified specialized "security guards" within the defense system that remove rogue immune cells that could attacking the body.
The discoveries are now paving the way for innovative therapies for immune disorders and cancer.
These laureates will divide a monetary award valued at 11m SEK.
Decisive Discoveries
"Their research has been essential for comprehending how the body's defenses functions and why we do not all develop severe autoimmune diseases," commented the chair of the award panel.
This team's research explain a core question: In what way does the immune system protect us from countless infections while keeping our own tissues intact?
The body's protection system employs white blood cells that search for indicators of infection, including pathogens and germs it has not met before.
These cells utilize detectors—called recognition units—that are produced randomly in a vast number of variations.
This gives the defense network the capacity to combat a wide array of threats, but the unpredictability of the process unavoidably creates white blood cells that may target the host.
Protectors of the Immune System
Scientists previously understood that a portion of these problematic white blood cells were eliminated in the immune organ—the site where immune cells mature.
The latest Nobel Prize honors the discovery of regulatory T-cells—known as the body's "security guards"—which travel through the body to disarm other immune cells that attack the healthy cells.
It is known that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.
A prize committee stated, "The discoveries have laid the foundation for a new field of research and spurred the development of new therapies, for instance for cancer and autoimmune diseases."
In cancer, T-regs block the body from attacking the growth, so research are aimed at reducing their quantity.
For autoimmune diseases, experiments are exploring boosting T-reg cells so the body is not being harmed. A comparable method could also be effective in minimizing the risks of organ transplant rejection.
Innovative Studies
Prof Sakaguchi, of Osaka University, conducted experiments on rodents that had their immune gland removed, leading to self-attack conditions.
He showed that introducing immune cells from healthy animals could prevent the disease—implying there was a mechanism for blocking defenders from harming the body.
Dr. Brunkow, from the a research center in Seattle, and Dr. Ramsdell, now at a biotech firm in a California city, were investigating an genetic autoimmune disease in rodents and people that resulted in the discovery of a genetic factor critical for how T-regs operate.
"Their groundbreaking work has revealed how the body's defenses is controlled by regulatory T cells, preventing it from accidentally targeting the body's own tissues," said a prominent biological science specialist.
"The work is a striking illustration of how basic biological research can have broad consequences for human health."
